Embolization agents-which one should be used when? Part 1: large-vessel embolization.
Embolization agents-which one should be used when? Part 1: large-vessel embolization.
复制标题
DOI：
10.1055/s-0029-1242206
复制
发表时间：
2009-12-01
影响因子：
1.4
通讯作者：
Funaki, Brian
中科院分区：
文献类型：
--
作者：
Lubarsky, Michael;Ray, Charles E;Funaki, Brian
1972年报道了第一例临床经导管栓塞术，使用自体凝块作为栓塞剂。从那时起，栓塞手术变得越来越复杂，栓塞剂的数量、种类和复杂性呈指数级增长。因此，在任何给定的栓塞手术之前，操作者必须做出的最困难的决定之一是使用什么栓塞剂。可以使用系统方法来确定大多数临床情况下的最佳栓塞剂。操作者必须做出的第一个决定是，是否可以安全地牺牲血管，而不会使下游器官处于重大风险之中。一旦决定可以牺牲血管，为了确定使用的最佳栓塞剂，术者应回答三个问题：
The first clinical transcatheter embolization procedure was reported in 1972, utilizing autologous clot as the embolic agent. Since then, embolization procedures have become progressively more sophisticated and the number, variety, and complexity of embolic agents has exponentially increased. Hence, one of the most difficult decisions an operator must make before any given embolization procedure is what embolic agent to use.A systematic approach can be used to determine the best agent for most clinical scenarios encountered. The first decision that must be made by the operator is whether or not a vessel can safely be sacrificed without putting the downstream organ (s) at significant risk. Once it is decided that the vessel can be sacrificed, to determine the best embolic agent to use, the operator should answer three questions: